Lv41
426 积分 2023-03-07 加入
CD48 is a novel immune checkpoint on tumour‐associated macrophages in hepatocellular carcinoma
1小时前
待确认
Targeting mTORC2-Dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET-activated and β-catenin-mutated hepatocellular carcinoma
1个月前
已关闭
Targeting mTORC2-Dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET-activated and β-catenin-mutated hepatocellular carcinoma
1个月前
已关闭
Glutamine synthetase loss in β-catenin-mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogramming
3个月前
已完结
皖公网安备34019202002308
